Psychosis happens when the brain begins misinterpreting its own signals, assigning intense meaning to things that wouldn’t normally register and, in some cases, generating sensory experiences that aren’t there. It affects roughly 1.5 to 3.5 percent of people at the level of a diagnosable disorder, though a larger number will experience at least one psychotic symptom at some point in their lives. The process involves changes in brain chemistry, genetics, and environmental stress working together, often over months or years before a full episode emerges.
What’s Happening in the Brain
The core problem in psychosis is a disruption in how the brain filters and prioritizes information. Normally, your brain constantly sorts what deserves your attention from background noise. During psychosis, this filtering system breaks down. The brain starts flagging ordinary things (a stranger’s glance, a license plate number, a background conversation) as deeply significant. Researchers call this “aberrant salience,” and brain imaging studies back it up: people experiencing psychosis show reduced brain activity when something genuinely meaningful happens and exaggerated responses to neutral stimuli. The world starts to feel pregnant with hidden significance, generating feelings of apprehension and a sense that something has fundamentally changed.
This misattribution of meaning is what eventually crystallizes into the hallmark symptoms of psychosis. Delusions form as the brain tries to construct explanations for why everything suddenly feels so important. Hallucinations emerge when the brain generates sensory information internally and treats it as coming from the outside world. These aren’t failures of intelligence or willpower. They’re the brain’s attempt to make sense of signals that have gone haywire.
The Chemical Shifts Behind It
Dopamine plays a central role. This chemical messenger helps the brain tag experiences as meaningful or rewarding. In psychosis, dopamine signaling in the striatum (a deep brain structure involved in motivation and movement) becomes dysregulated. Too much dopamine activity in certain pathways causes the brain to over-tag neutral experiences as important, fueling delusions and hallucinations. This is why most antipsychotic medications work by dialing down dopamine activity, and why stimulant drugs that flood the brain with dopamine can trigger psychotic episodes.
But dopamine isn’t the whole story. Another signaling system involving glutamate, the brain’s main excitatory messenger, also appears to malfunction. Drugs that block a specific type of glutamate receptor (the NMDA receptor) produce symptoms that closely mimic psychosis, including not just hallucinations and delusions but also the withdrawal, flat emotions, and cognitive difficulties that dopamine disruption alone doesn’t fully explain. When these receptors aren’t working properly, inhibitory neurons that normally keep brain circuits in check become underactive. The result is a cascade: excitatory pathways become hyperactive, neural circuits become noisy, and the brain loses its ability to distinguish signal from noise.
Genetics Set the Stage
Psychosis has a strong hereditary component. Based on the Danish Twin Register, the heritability of schizophrenia is estimated at 79 percent, meaning that a large majority of the variation in risk comes from genetic factors. If one identical twin develops schizophrenia, the other has a 33 percent chance of developing it too, compared to 7 percent for non-identical twins.
That 33 percent concordance rate is telling in both directions. Genes clearly matter a great deal, but they aren’t destiny. Two people with identical DNA have only a one-in-three chance of sharing the condition. No single gene causes psychosis. Instead, hundreds of small genetic variations each nudge the brain’s wiring and chemistry in ways that, collectively, can raise vulnerability. Whether that vulnerability becomes an actual episode depends heavily on what happens in a person’s life.
Environmental Triggers That Push the Brain Over
Psychosis emerges from the interaction between genetic vulnerability and environmental stress. The most well-established triggers include childhood trauma, cannabis use (particularly heavy use starting in adolescence), complications during birth, neurological trauma, growing up in an urban environment, and migration. These risk factors don’t just add up; they compound. Research shows a dose-response effect: people with two risk factors develop psychosis earlier than those with one.
Cannabis deserves special attention because its role is often underestimated. Heavy cannabis use, particularly of high-potency strains during adolescence when the brain is still developing, is associated with significantly earlier onset of psychosis. It appears to act on the same dopamine pathways that are already vulnerable in people with genetic predisposition, effectively accelerating a process that might otherwise have taken years longer to manifest, or might never have manifested at all.
The Slow Build Before a First Episode
Psychosis rarely arrives without warning. The onset is typically preceded by weeks, months, or even years of subtle changes known as the prodromal phase. Early on, these changes look nothing like what most people associate with psychosis. They resemble depression, anxiety, or general struggle: social withdrawal, difficulty concentrating, declining performance at school or work, sleep disturbances, a drop in motivation, and increased sensitivity to stress.
Closer to a full episode, subtler perceptual and cognitive shifts appear. A person might notice unusual thoughts that feel intrusive but still recognizable as odd. They might experience brief perceptual disturbances (hearing their name called when no one spoke, seeing fleeting shadows) that occur infrequently, perhaps once or twice a month, and last only minutes. Speech patterns may become slightly disorganized. These “attenuated” symptoms hover below the threshold of full psychosis in terms of frequency, duration, and intensity, but they represent the brain’s filtering systems beginning to falter. The peak age window for this to happen is the teens through the mid-20s for males and the teens through the late 20s for females.
Medical Conditions That Mimic Psychosis
Not all psychosis originates in the brain’s own wiring. A wide range of medical conditions can produce identical symptoms, and identifying these is critical because treating the underlying condition often resolves the psychosis entirely.
- Thyroid disorders: Both overactive and underactive thyroid function can cause psychotic symptoms. An estimated 5 to 15 percent of people with severe hypothyroidism experience some form of psychosis.
- Autoimmune conditions: Lupus can present with psychosis in 1 to 11 percent of cases, and up to 80 percent of those develop psychiatric symptoms within the first year of their lupus diagnosis. NMDA receptor encephalitis, an autoimmune condition where the body attacks the same brain receptors involved in glutamate signaling, can look indistinguishable from a primary psychotic disorder.
- Seizure disorders: Temporal lobe epilepsy and partial complex seizures can produce hallucinations, paranoia, and altered perception.
- Nutritional deficiencies: Severe B12 deficiency, vitamin D deficiency, and pellagra (niacin deficiency) have all been documented to cause psychotic symptoms.
- Head injuries and brain tumors: Any structural damage or pressure on the brain can disrupt the circuits responsible for perception and cognition.
- Substances and medications: Beyond street drugs like PCP, LSD, and methamphetamine, prescribed medications including steroids and certain antimalarials can trigger psychosis.
This is why a thorough medical workup matters when someone presents with psychotic symptoms for the first time. The brain is ultimately a physical organ, and anything that disrupts its blood supply, hormone environment, immune function, or nutrient availability can produce symptoms that look psychiatric but have a treatable medical cause.
Recovery After a First Episode
Psychosis is not necessarily a permanent condition. After a first episode, about 54 percent of people achieve symptomatic remission, meaning their hallucinations, delusions, and other acute symptoms resolve substantially. This was measured across 76 studies with an average follow-up of roughly three and a half years. Full recovery, which includes not just symptom resolution but a return to normal social and occupational functioning, occurs in about 32 percent of cases over a longer follow-up period averaging six years.
Early intervention makes a meaningful difference. The longer psychosis goes untreated, the more difficult recovery tends to be, which is why recognizing those prodromal warning signs matters. The brain appears to be more responsive to treatment when the duration of untreated psychosis is shorter, and the social consequences (job loss, relationship breakdown, educational disruption) have less time to accumulate. For many people, a first psychotic episode is a treatable medical event, not a life sentence.